Hepatocellular carcinoma: diagnostics and screening
Authors:
- Mohamed I.F. ShariffMSMohamed I.F. Shariff
- Nimzing G. LadepNLNimzing G. Ladep
- Andrew V. ThillainayagamATAndrew V. Thillainayagam
- Howard C. ThomasHTHoward C. Thomas
- Shahid A. KhanSKShahid A. Khan
- Simon D. Taylor‐RobinsonSTSimon D. Taylor‐Robinson
- 30 November 2010
- journal article
- review article
- Published by Wiley in Journal of Evaluation in Clinical Practice
- Vol. 18 (2) , 335-342
Abstract
Hepatocellular carcinoma (HCC) is the commonest primary hepatic malignancy and the third most common cause of cancer‐related death worldwide. Incidence remains highest in the developing world and is steadily increasing across the developed world. The majority of HCC occurs on a background of cirrhosis, principally caused by two major risk factors, chronic hepatitis B and hepatitis C infection. Current diagnostic modalities, of ultrasound and α‐fetoprotein, are expensive and lack sensitivity in tumour detection. Early diagnosis is integral to improved survival rates and there have been recent advances in technology that have enabled early identification of the process of hepatocarcinogenesis. This review outlines the epidemiological trends and risk factors for HCC; diagnostic techniques and current guidelines for screening and surveillance; and newer methods of screening.Keywords
This publication has 56 references indexed in Scilit:
- Hepatocellular Carcinoma: Epidemiology, Surveillance, and DiagnosisSeminars in Liver Disease, 2010
- Present and future possibilities for early diagnosis of hepatocellular carcinomaWorld Journal of Gastroenterology, 2010
- Hepatocellular carcinoma: current trends in worldwide epidemiology, risk factors, diagnosis and therapeuticsExpert Review of Gastroenterology & Hepatology, 2009
- Hepatocellular carcinoma: ESMO Clinical Recommendations for diagnosis, treatment and follow-upAnnals of Oncology, 2009
- Radiological diagnosis of hepatocellular carcinomaLiver International, 2008
- Gender Disparity in Liver Cancer Due to Sex Differences in MyD88-Dependent IL-6 ProductionScience, 2007
- Management of Hepatocellular Carcinoma *Hepatology, 2005
- Incidence and Cofactors of Hepatitis C Virus-related Hepatocellular Carcinoma: A Prospective Study of 12,008 Men in TaiwanAmerican Journal of Epidemiology, 2003
- Hepatocellular Carcinoma in Italian Patients with CirrhosisNew England Journal of Medicine, 1991
- HEPATOCELLULAR CARCINOMA AND HEPATITIS B VIRUSThe Lancet, 1981